Advent leads race to buy US pharma research firm inVentiv for close to $4b

Advent leads race to buy US pharma research firm inVentiv for close to $4b

Greg Roumeliotis

01 August, 2016

Advent InternationalCVC Capital PartnersinVentivGroup HoldingsThomas H. Lee Partners

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter

Read more from World

Nikkei Logo
DealStreetAsia Logo
About Us
Team
Advertise
Contact
Careers
Blog
Privacy Policy
Terms & Conditions
© Copyright DEALSTREETASIA 2014-2025 All rights reserved.